Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic
Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well…
Pamela Roff, B.S. on LinkedIn: Vagus Nerve Dysfunction in the Post-COVID-19 Condition
Why Physicians Commit Suicide - Pamela Wible MD
Pamela Roff, B.S. - Provider Relations - South Denver Cardiology Associates
Pamela Roff, B.S. - Provider Relations - South Denver Cardiology Associates
Rishad Usmani, MD on LinkedIn: There is tension between personalized care and evidence based care…
Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…
Pamela Roff, B.S. on LinkedIn: Research News: Researchers in Germany recently described a group of…
Pamela Roff, B.S. on LinkedIn: Vagus Nerve Dysfunction in the Post-COVID-19 Condition
Pamela Roff, B.S. on LinkedIn: What is POTS?
Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…
Pamela Roff, B.S. on LinkedIn: CALLING ALL RESEARCHERS! Dysautonomia International is now accepting grant…
Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic
Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…